EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Clinical Colorectal Cancer

ISSN 1533-0028 · Elsevier BV

Latest articles

  1. Real-world use of encorafenib plus cetuximab after prior systemic therapy in patients with BRAFV600E-mutant metastatic colorectal cancer: a pooled analysis of European observational studies

    Chiara Cremolini, Julien Taieb, Erika Martinelli, Ana Fernandez Montes, Elena Elez, Jeanine M.L. Roodhart, Annabel Alig, Marco Maria Germani, Claire Gallois, Paula Sampedro Domarco, Miriam Koopman, Hanane Attar, Kalaivani Ruhier, Florence Carrère, Sebastian Stintzing

    Published: 2026-11DOI: 10.1016/j.clcc.2026.11.001

  2. EGFR Targeting With Afatinib and Cetuximab Versus Cetuximab Alone in Chemorefractory Wild-type RAS Metastatic Colorectal Cancer: A Randomized Phase II Study With Circulating Tumor Cell Analysis

    Victor Simmet, Astrid Lièvre, Emmanuelle Samalin, Hélène Senellart, Christelle De La Fouchardière, Christophe Borg, Antoine Adenis, David Malka, Véronique Guerin-Meyer, Ludovic Evesque, Meher Ben Abdelghani, Julien Edeline, Thierry André, Francois Ghiringhelli, Jean-Luc Raoul, Laure Monard, Sophie Gourgou, Jaafar Bennouna

    Published: 2026-09DOI: 10.1016/j.clcc.2026.09.001

  3. Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia

    Grace Y. Kim, Vanessa Wong, Matthew Loft, Belinda Lee, Rachel Wong, Geoff Chong, Azim Jalali, Mun Sem Liew, Natalie Rainey, Matthew Burge, Theresa Hayes, Niall C. Tebbutt, Sue-Anne McLachlan, Hiren Mandaliya, Sarah Sutherland, Shu Fen Wong, Stephanie H. Lim, Louise Nott, Ayesha Saqib, Julie van Bavel, Elani Bowers, Julie Johns, Peter Gibbs

    Published: 2026-09DOI: 10.1016/j.clcc.2026.09.003

  4. Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study

    Manish A. Shah, Takayuki Yoshino, Niall C. Tebbutt, Axel Grothey, Josep Tabernero, Rui-Hua Xu, Andres Cervantes, Sang Cheul Oh, Kensei Yamaguchi, Marwan Fakih, Alfredo Falcone, Christina Wu, Vi K. Chiu, Jiri Tomasek, Johanna Bendell, Marilyn Fontaine, Matthew Hitron, Bo Xu, Julien Taieb, Eric Van Cutsem

    Published: 2023-03DOI: 10.1016/j.clcc.2022.11.002

Volumes

2026 · 562025 · 742024 · 512023 · 652022 · 822021 · 862020 · 882019 · 902018 · 1272017 · 892016 · 872015 · 562014 · 502013 · 482012 · 472011 · 602010 · 572009 · 462008 · 652007 · 642006 · 712005 · 712004 · 542003 · 412002 · 382001 · 33

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.